Literature DB >> 27035814

The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells.

.   

Abstract

Entities:  

Year:  2016        PMID： 27035814      PMCID： PMC4811160          DOI： 10.1172/JCI87345

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  1 in total

1.  The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma.

Authors:  Rosa Marina Melillo; Anna Maria Cirafici; Valentina De Falco; Marie Bellantoni; Gennaro Chiappetta; Alfredo Fusco; Francesca Carlomagno; Antonella Picascia; Donatella Tramontano; Giovanni Tallini; Massimo Santoro
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307
  1 in total
  2 in total

1.  Association of microRNA-related gene XPO5 rs11077 polymorphism with susceptibility to thyroid cancer.

Authors:  Jing Wen; Qingjun Gao; Nanpeng Wang; Wei Zhang; Kun Cao; Qiang Zhang; Shi Chen; Lixin Shi
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

Review 2.  Chasing the Target: New Phenomena of Resistance to Novel Selective RET Inhibitors in Lung Cancer. Updated Evidence and Future Perspectives.

Authors:  Sara Fancelli; Enrico Caliman; Francesca Mazzoni; Marco Brugia; Francesca Castiglione; Luca Voltolini; Serena Pillozzi; Lorenzo Antonuzzo
Journal:  Cancers (Basel)       Date:  2021-03-04       Impact factor: 6.639
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.